DZ Bank Raises Price Target for argenx

DZ Bank analyst Elmar Kraus has increased the price target for argenx (ARGX) to 935 EUR from 861 EUR, citing better-than-expected product sales for its flagship therapy, VYVGART. The firm has maintained a 'Buy' rating on the stock following the company's recent quarterly results.